PUBLISHER: TechNavio | PRODUCT CODE: 2109490
PUBLISHER: TechNavio | PRODUCT CODE: 2109490
Global Carrier Screening Market 2026-2030
The global carrier screening market is forecasted to grow by USD 3384.2 mn during 2025-2030, accelerating at a CAGR of 18.1% during the forecast period. The report on the global carrier screening market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by technological advancements and widespread adoption of next-generation sequencing, rising prevalence of genetic disorders and growing consumer awareness regarding preventive healthcare, integration of carrier screening into routine obstetric guidelines and assisted reproductive technology workflows.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 16.3% |
| CAGR | 18.1% |
| Incremental Value | $3384.2 mn |
Technavio's global carrier screening market is segmented as below:
By Type
- Expanded
- Targeted disease
By Technology
- DNA sequencing
- PCR
- Microarrays
- Others
By Test
- Molecular screening tests
- Biochemical screening tests
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the accelerated shift toward pan-ethnic expanded carrier screening over ancestry-based models as one of the prime reasons driving the global carrier screening market growth during the next few years. Also, transition from fragmentation to consolidated workflow automation via long-read sequencing technologies and commercial bundling of preconception screening with in-vitro fertilization and preimplantation diagnostics will lead to sizable demand in the market.
The report on the global carrier screening market covers the following areas:
- Global carrier screening market sizing
- Global carrier screening market forecast
- Global carrier screening market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global carrier screening market vendors that include Ambry Genetics, Baylor Genetics, BGI Genomics Co. Ltd., Blueprint Genetics Oy, Centogene N.V., CooperSurgical Inc., Eurofins Scientific SE, Fulgent Genetics Inc., GeneDx LLC, Genomic Diagnostics, Igenomix, Juno Genetics Ltd, KBI Services Inc., Laboratory Holdings Inc., MedGenome Inc., Myriad Genetics Inc., Natera Inc., Orchid Health, Quest Diagnostics Inc., Reproductive Genetic Innovations. Also, the global carrier screening market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Market Segmentation by Test
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Carrier Screening Market 2020 - 2024
- Historic Market Size - Data Table on Global Carrier Screening Market 2020 - 2024 ($ million)
- 5.2 Type segment analysis 2020 - 2024
- Historic Market Size - Type Segment 2020 - 2024 ($ million)
- 5.3 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.4 Test segment analysis 2020 - 2024
- Historic Market Size - Test Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on global carrier screening market
- 6.2 Impact of geopolitical conflicts on global carrier screening market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Type
- 8.1 Market segments
- 8.2 Comparison by Type
- 8.3 Expanded - Market size and forecast 2025-2030
- 8.4 Targeted disease - Market size and forecast 2025-2030
- 8.5 Market opportunity by Type
- Market opportunity by Type ($ million)
9 Market Segmentation by Technology
- 9.1 Market segments
- 9.2 Comparison by Technology
- 9.3 DNA sequencing - Market size and forecast 2025-2030
- 9.4 PCR - Market size and forecast 2025-2030
- 9.5 Microarrays - Market size and forecast 2025-2030
- 9.6 Others - Market size and forecast 2025-2030
- 9.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)
10 Market Segmentation by Test
- 10.1 Market segments
- 10.2 Comparison by Test
- 10.3 Molecular screening tests - Market size and forecast 2025-2030
- 10.4 Biochemical screening tests - Market size and forecast 2025-2030
- 10.5 Market opportunity by Test
- Market opportunity by Test ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 Japan - Market size and forecast 2025-2030
- 12.5.2 China - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Indonesia - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Turkey - Market size and forecast 2025-2030
- 12.6.5 Argentina - Market size and forecast 2025-2030
- 12.6.6 Colombia - Market size and forecast 2025-2030
- 12.6.7 South Africa - Market size and forecast 2025-2030
- 12.6.8 Israel - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Technological advancements and widespread adoption of next-generation sequencing
- Rising prevalence of genetic disorders and growing consumer awareness regarding preventive healthcare
- Integration of carrier screening into routine obstetric guidelines and assisted reproductive technology workflows
- 13.2 Market challenges
- Inconsistent reimbursement frameworks and high out-of-pocket testing costs
- Shortage of certified genetic counselors and clinical data interpretation deficits
- Complex regulatory environments and fragmented data privacy compliance laws
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Accelerated shift toward pan-ethnic expanded carrier screening over ancestry-based models
- Transition from fragmentation to consolidated workflow automation via long-read sequencing technologies
- Commercial bundling of preconception screening with in-vitro fertilization and preimplantation diagnostics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Ambry Genetics
- Ambry Genetics - Overview
- Ambry Genetics - Product / Service
- Ambry Genetics - Key offerings
- SWOT
- 15.5 Baylor Genetics
- Baylor Genetics - Overview
- Baylor Genetics - Product / Service
- Baylor Genetics - Key offerings
- SWOT
- 15.6 BGI Genomics Co. Ltd.
- BGI Genomics Co. Ltd. - Overview
- BGI Genomics Co. Ltd. - Product / Service
- BGI Genomics Co. Ltd. - Key offerings
- SWOT
- 15.7 Blueprint Genetics Oy
- Blueprint Genetics Oy - Overview
- Blueprint Genetics Oy - Product / Service
- Blueprint Genetics Oy - Key offerings
- SWOT
- 15.8 Centogene N.V.
- Centogene N.V. - Overview
- Centogene N.V. - Product / Service
- Centogene N.V. - Key offerings
- SWOT
- 15.9 CooperSurgical Inc.
- CooperSurgical Inc. - Overview
- CooperSurgical Inc. - Product / Service
- CooperSurgical Inc. - Key offerings
- SWOT
- 15.10 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.11 Fulgent Genetics Inc.
- Fulgent Genetics Inc. - Overview
- Fulgent Genetics Inc. - Product / Service
- Fulgent Genetics Inc. - Key offerings
- SWOT
- 15.12 GeneDx LLC
- GeneDx LLC - Overview
- GeneDx LLC - Product / Service
- GeneDx LLC - Key offerings
- SWOT
- 15.13 Genomic Diagnostics
- Genomic Diagnostics - Overview
- Genomic Diagnostics - Product / Service
- Genomic Diagnostics - Key offerings
- SWOT
- 15.14 Juno Genetics Ltd
- Juno Genetics Ltd - Overview
- Juno Genetics Ltd - Product / Service
- Juno Genetics Ltd - Key offerings
- SWOT
- 15.15 MedGenome Inc.
- MedGenome Inc. - Overview
- MedGenome Inc. - Product / Service
- MedGenome Inc. - Key offerings
- SWOT
- 15.16 Myriad Genetics Inc.
- Myriad Genetics Inc. - Overview
- Myriad Genetics Inc. - Product / Service
- Myriad Genetics Inc. - Key offerings
- SWOT
- 15.17 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Business segments
- Natera Inc. - Key offerings
- Natera Inc. - Segment focus
- SWOT
- 15.18 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
